BIMI Announces Results of 2023 Annual General Meeting of Stockholders
New York, Jan. 03, 2024 (GLOBE NEWSWIRE) — BIMI Holdings Inc. (NASDAQ: BIMI) (“BIMI” or the “Company”), previously known as […]
Immunocore to present at the 42nd Annual J.P. Morgan Healthcare Conference
Immunocore to present at the 42ndAnnual J.P. Morgan Healthcare Conference (OXFORDSHIRE, England & CONSHOHOCKEN, Penn. & ROCKVILLE, Md., US, 03 […]
Hepsiburada’s New CFO M. Seçkin Köseoğlu Takes Office Effective January 1, 2024
ISTANBUL, Türkiye, Jan. 03, 2024 (GLOBE NEWSWIRE) — D-MARKET Electronic Services & Trading (d/b/a “Hepsiburada”) (NASDAQ: HEPS), a leading Turkish […]
Atea Pharmaceuticals to Present at the 42nd Annual J.P. Morgan Healthcare Conference
BOSTON, Jan. 03, 2024 (GLOBE NEWSWIRE) — Atea Pharmaceuticals, Inc. (Nasdaq: AVIR) (“Atea”), a clinical-stage biopharmaceutical company engaged in the […]
IGM Biosciences to Present at the 42nd Annual J.P. Morgan Healthcare Conference
MOUNTAIN VIEW, Calif., Jan. 03, 2024 (GLOBE NEWSWIRE) — IGM Biosciences, Inc. (Nasdaq: IGMS), a clinical-stage biotechnology company creating and […]
Akoustis to Attend CES 2024 Conference in Las Vegas from January 9-12
Charlotte, N.C., Jan. 03, 2024 (GLOBE NEWSWIRE) — Akoustis Technologies, Inc. (NASDAQ: AKTS) (“Akoustis” or the “Company”), an integrated device […]
Tonix Pharmaceuticals to Present at Two Upcoming Investor Conferences in January: Focus is on TNX-102 SL for the Management of Fibromyalgia Following Positive Topline Results in Second Pivotal Phase 3 Trial
TNX-102 SL is a Non-Opioid Analgesic that Demonstrated Daily Pain Reduction Over Placebo (Primary Endpoint, p = 0.00005) and Showed […]
TSX News -
Ascot Intercepts High-Grade Gold at the Big Missouri Deposit, Including 58.2 g/t Over 2.0 Metres and 9.9 g/t Over 6.9 Metres
VANCOUVER, British Columbia, Jan. 03, 2024 (GLOBE NEWSWIRE) — Ascot Resources Ltd. (TSX: AOT; OTCQX: AOTVF) (“Ascot” or the “Company”) […]
TSX News -
Microbix Achieves Further QAPs Sales Record
MISSISSAUGA, Ontario, Jan. 03, 2024 (GLOBE NEWSWIRE) — Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator, […]
TSX News -
ProMIS Neurosciences, Inc. Announces Leadership Transition
CAMBRIDGE, Massachusetts and TORONTO, Ontario, Jan. 03, 2024 (GLOBE NEWSWIRE) — ProMIS Neurosciences Inc. (Nasdaq: PMN), a biotechnology company focused […]
